Half of the world’s population has little to no access to diagnostics for infectious diseases, even though they often carry the global burden. Almost every global health priority (antimicrobial resistance, global health security) depends on better access to quick and accurate diagnostic tests for infectious diseases.

Our center identifies promising emerging technologies, particularly those that are affordable and useful in resource-limited settings, and facilitates their translational movement along the development pipeline into clinical assessment and commercialization.